3.4.21.20	azurophil granule	-	42582	36500, 664269, 665169, 665913, 709987	
3.4.21.20	cell surface	-	9986	718143, 753787	
3.4.21.20	cell surface	active enzyme	9986	683193	
3.4.21.20	cell surface	expression at high levels on the surface of activated human neutrophils in catalytically active but inhibitor-resistant form	9986	683644	
3.4.21.20	cytoplasmic vesicle	-	31410	653667	
3.4.21.20	endocytic vesicle	-	30139	709987	
3.4.21.20	extracellular	-	-	653069, 653984	
3.4.21.20	extracellular	active enzyme	-	683193	
3.4.21.20	extracellular	enzyme is released on degranulation of neutrophils	-	651583	
3.4.21.20	intracellular	-	5622	709983	
3.4.21.20	lysosome	-	5764	36500, 36501, 665912, 709353	
3.4.21.20	lysosome	derived from primary murine microglia	5764	683531	
3.4.21.20	lysosome	microglia-derived	5764	683531	
3.4.21.20	membrane	-	16020	36519, 36523, 718414	
3.4.21.20	nucleus	apoptotic NB4 cells	5634	653667	
3.4.21.20	plasma membrane	mechanism by which the enzyme binds to activated human neutrophil plasma membranes, a functional active site is not required for binding, overview, inhibition of binding by 1. trypsin, chondroitinase ABC, and heparitinases, but not other glycanases, and by 2. purified chondroitin sulfates, heparan sulfate, and other sulfated molecules, but not by non-sulfated glycans, binding kinetics, overview	5886	683644